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Introduction 
 
Over the past 150 years, the average life expectancy has dramatically increased from 40 
years to 80 years (Aw, Silva, & Palmer, 2007). Due to continued advances in medicine, the 
relative proportion of people over the age of 65 is predicted to increase from its present 18% to 
25% of the worldwide population by 2031 (Aw et al., 2007). Due to the rapid expansion of this 
age demographic, there is an increased need for research that identifies specific issues that the 
older population will face in order to help them enjoy long, healthy lives.   
For most people, late life is associated with improved emotion regulation and an increased 
motivation to focus one’s attention on emotionally gratifying information (Carstensen & Mikels, 
2005). However, for some proportion of the older population, depressive symptoms will interfere 
with their ability to experience satisfaction with their lives. In older adults, both clinical and 
subthreshold depression diagnoses have been linked to severe impairment and health risks (e.g., 
Beekman, Deeg, Braam, Smit, & van Tilburg, 1997; Beekman et al., 2002; Bruce, 2001). 
Therefore, it is logical that clinicians and researchers would want to know as much as possible 
about the prevalence, etiology, course, and most beneficial form of treatment of depressive 
disorders in the geriatric population. 
In the general population, the lifetime prevalence of Major Depressive Disorder (MDD) is 
believed to be between 10% and 25% in women, and from 5% to 12% in men (DSM-IV-TR, 
2000). A review of the existing literature on age effects on depression revealed that past studies 
that attempted to quantify the prevalence of depression in the older adult population have yielded 
mixed results due, in part, to differences in diagnostic methods. Without a standard method for 
defining and diagnosing depression in older individuals, a coherent understanding of age-related 
changes in depression cannot be reached. In addition, the lack of standardization in assessment 
methods can lead to unreliable diagnoses on the part of clinicians, resulting in older adults not 
always receiving appropriate treatment for their symptoms. 
The following paper reviews the literature on the diagnosis of clinical depression in elderly 
individuals. The development of the existing assessment techniques and the movement toward a 
standardized diagnostic technique will be discussed. In addition, the methods of control used in 
research for defining and diagnosing depression will be critiqued. Pros and cons of available 
control and assessment techniques will be considered, and suggestions will be made for future 
  
research endeavors in this field. 
 
Characterizing Depression 
 
Some of the discrepancy in the literature over the prevalence of depression in advanced age 
stems from the fact that some studies characterize depression as MDD as defined in the 
Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; DSM–IV–TR; 
American Psychiatric Association, 2000), whereas other studies define depression in terms of the 
number of depressive symptoms one experiences, without the necessity of an MDD diagnosis. 
The DSM-IV-TR defines MDD as the presence of one or more Major Depressive Episodes 
without the presence of any Manic, Hypomanic, or Mixed Episodes or Psychotic Disorders.  
MDD may consist of a single Major Depressive Episode, or it may be recurrent.  The current 
clinical status and features of the MDD may be further specified.  Older adults are more likely to 
present with Melancholic Features than other forms of MDD (Blazer, 2003; Parker, Roy, Hadzi-
Pavlovic, Wilhelm, & Mitchell, 2001), in contrast to younger adults, who are more likely to 
experience Atypical Features (DSM-IV-TR, 2000).   
Overall, the prognosis for older adults with MDD is very poor (Beekman et al., 2002). MDD 
has been linked to severe impairments in the elderly population including increased risk of 
mortality (Beekman et al., 2002) and increased likelihood of disability (Bruce, 2001). Imaging 
research indicates that severe MDD is associated with decreased volume in the prefrontal lobes 
(Kumar, Jin, Bilker, Udupa, & Gottlieb, 1998), which may contribute to the cognitive difficulties 
often reported in late-life depression (DSM-IV-TR, 2000). Specific cognitive difficulties that are 
associated with MDD include impairments in verbal recall and mental flexibility (Elderkin-
Thompson et al., 2003). 
However, research indicates that even subclinical levels of depressive symptoms can still be 
chronic and debilitating in older adults. If an individual presents with between two and four of 
the Major Depressive Episode features, he or she is considered to have subthreshold depression, 
also referred to as Minor Depressive Disorder (Blazer, 2003; DSM-IV-TR, 2000). The DSM-IV-
TR (2000) states that, on average, people with Minor Depressive Disorder are significantly less 
impaired than people with MDD and may be able to function at nearly normal levels, although it 
may require more effort than usual to complete one’s daily tasks. For elderly people with minor 
depression, however, the prognosis is still unfavorable, although not as poor as that for elderly 
sufferers of MDD (Beekman et al., 2002).  For example, older adults with subclinical depression 
are at high risk for developing clinically significant affective disorders (Beekman et al., 2002). 
Minor depression is also associated with deteriorating physical health, in contrast with major 
depression, which seems to be independent of physical health (Beekman et al., 1997). 
Subclinical depression can also lead to impaired executive functioning in elders (Elderkin-
Thompson et al., 2003). 
Both MDD and minor depressive symptoms are associated with excessive use of public 
health services such as hospitals and social work agencies (Beekman et al., 1997). This finding 
  
has significant public health implications, as healthcare is costly, and the overuse of public health 
services by older adults can overwhelm some aspects of the public healthcare system. It is also 
important to note that depressed elders experiencing financial difficulties or legal struggles may 
seek the help of public service providers such as social workers, not realizing that their problems 
may stem from depression (Brink et al., 1982). If the individual’s symptoms are somatic, as they 
often are in old age, they might seek treatment from physicians for their physical ailments. It has 
been reported that older adults are reluctant to seek the help of mental healthcare specialists, 
perhaps due to a negative view of mental health issues (Brink et al., 1982). This bias might lead 
elders to seek the help of public servants who do not specialize in mental health.  However, these 
workers, not being trained in the recognition and treatment of depression to the same degree as 
psychiatrists, will not be able to treat the root of these individuals’ impairments. As a result, any 
benefits the older individuals receive from this sort of assistance will be short-lived, and the 
cycle of misdiagnosis, impairment, and overuse of public services will continue. 
It is important to take note of how depression is defined when looking at studies that assess 
the prevalence of depression in the older adult community. Many studies that assessed 
depression along a continuous scale found a U-shaped association between age and the number 
of depressive symptoms reported in individuals, such that depressive symptoms decrease in 
frequency until middle age and increase in frequency throughout early and late old age (e.g., 
Blazer, Burchett, Service, & George, 1991; Wu, Schimmele, & Chappell, 2011; Yang, 2007).  
However, when depression is categorized in terms of meeting the diagnostic criteria for MDD, a 
negative association between advanced age and depression is often found (e.g. Jorm, 2000; 
Yang, 2007). Additionally, the way in which depression is defined affects the absolute 
prevalence rates. For example, a 1995 cross-sectional study of older adults in The Netherlands 
found that while the prevalence of MDD was only 2.02%, 14.9% of the population had clinically 
relevant levels of depressive symptoms, encompassing both major and minor depression 
(Beekman et al., 1995). Clearly, variation in the definition of depression has contributed to much 
of the divergence in the literature regarding the prevalence of late-life depression.   
The discovery that major depression and minor depression have different etiologies 
highlights the importance of differential diagnosis. Subthreshold depression seems to develop as 
a reaction to exogenous stressors associated with late life such as loneliness and poor subjective 
health (Beekman et al., 1995). In contrast, late-life MDD is associated with personal and family 
histories of mood disorders (Beekman et al., 1995). These differences clearly show that major 
and minor depression are different syndromes and should be addressed differently in both the 
research and clinical domains. 
Knowledge of the etiological differences between major and minor depression is essential in 
the clinical setting for selecting the appropriate treatment for the patient’s syndrome. While the 
first line of therapy for MDD is treatment with serotonin-selective reuptake inhibitors (SSRI) and 
psychotherapy, SSRIs are not usually recommended for treatment of Minor Depressive Disorder 
unless the symptoms become chronic (Blazer, 2003). Thus, older adults suffering from minor 
depression are generally advised to take part in psychotherapy to address the stressors that are 
  
causing their suffering and impairment. Accurate diagnosis of depression by clinicians is 
particularly essential for older adults, as misdiagnosis can have severe consequences. False 
diagnosis with MDD in an individual who is only experiencing minor depressive symptoms can 
lead to unnecessary pharmacological interventions, which may exacerbate the individual’s 
existing symptoms and actually worsen their suffering (Cooke & Tucker, 2001). In addition, 
depression that is left untreated can result in the problems discussed earlier, including increased 
impairment and suicidality.   
Despite the growth of research that emphasizes the importance of accurate diagnosis, 
diagnostic accuracy remains an issue among healthcare providers. For example, in a 2001 study 
of six nursing homes in New York, fewer than 50% of cases of MDD were accurately recognized 
and diagnosed by nurses and social workers on the nursing home staff (Teresi, Abrams, Holmes, 
Ramirez, & Eimicke, 2001). 
Once depression is defined, how is it determined which individuals meet the criteria for that 
definition? The following section discusses the ways in which depression has been assessed in 
past studies that investigated the role of age in depression. 
 
Available Techniques for Assessment of Depression in Older Adults 
 
The diagnostic criteria provided by the DSM-IV-TR (2000) are currently the most widely 
agreed-upon set of criteria used to diagnose MDD and other depressive disorders (Cooke & 
Tucker, 2001). However, there is variation in the methods that clinicians and researchers use to 
determine which of these criteria an elderly individual meets. 
The Center for Epidemiologic Studies Depression Scale (CES-D) was developed in the 1960s 
to measure depressive symptoms in the general population (Radloff, 1977). The 30-item CES-D 
was originally included as part of a longer structured interview used to assess a variety of 
psychological constructs including mood, well-being, and social desirability. However, many 
researchers use the CES-D alone to measure how many depressive symptoms an individual has 
from each of the major components of depression, defined as depressed mood, feelings of guilt 
and worthlessness, feelings of helplessness and hopelessness, psychomotor retardation, loss of 
appetite, and sleep disturbance (Radloff, 1977). Individuals rate the frequency with which they 
experience each symptom on a scale from zero to three. The CES-D has been validated against 
many other depression scales, has been tested in a variety of demographic populations, and is 
considered to be highly reliable when assessing depression in the general population (Radloff, 
1977; Watson & Pignone, 2003). However, in elderly populations, the CES-D has been found to 
be less sensitive for diagnosing minor depression than MDD (Watson & Pignone, 2003).   
The Geriatric Depression Scale (GDS) was developed in the early 1980s when researchers 
began to notice that depressed older adults often presented with features that were distinct from 
those typically reported in younger and middle-aged adults (Montorio & Izal, 1996). In 
particular, the scale did not include somatic symptoms due to the prevalence of confusion in 
older adults about whether their physical symptoms were a result of depression, a general 
  
medical condition, or the normal effect of the aging process on the human body (Brink et al., 
1982; Montorio & Izal, 1996; Watson & Pignone, 2003). The GDS also uses a simplified yes/no 
answer format in order to reduce confusion in elderly people who may be experiencing cognitive 
decline. The GDS can be used in its full, 30-item format or in an abridged, 15-item format for 
expedited administration1. Like the CES-D, the GDS has been extensively evaluated and 
validated against other scales (Brink et al., 1982; Watson & Pignone, 2003). The 15-item GDS 
has been found to be more sensitive than the CES-D at detecting minor depression in older adults 
(Watson & Pignone, 2003). 
The CES-D and GDS are both self-report scales, which have costs and benefits in both the 
clinical and research domains. One advantage of self-report scales is that they can be used to 
quickly screen and categorize patients without the need for extensive interviewing and 
observation, which can help clearly disordered individuals receive treatment faster (Brink et al., 
1982). The need for fast treatment is particularly important for the depressed elderly, who are at 
high risk for suicidal ideation (Blazer, 2003) and completed suicide (Cooke & Tucker, 2001). 
However, an alternative view of this expedited clinical process is that patients who are on the 
borders of the cut-off scores for clinical significance might benefit from a more lengthy and in-
depth diagnosis protocol. In this way, more detailed structured and semi-structured interviews 
could lead to reductions in both false positives and false negatives when diagnosing depression.   
The following section encompasses a fuller discussion of limitations of past research. It also 
makes suggestions for ways in which future researchers can address these limitations, which will 
ultimately benefit both the research and clinical domains. 
 
Issues of Control and Directions for Future Research 
 
It is not clear from the literature why some studies assess depression in older adults using the 
CES-D, others use the GDS, and others use the two in conjunction with each other or with other 
depression scales. At first glance, it seems as though the GDS should always be the better choice 
for diagnosing late-life depression due to its simplicity and the omission of the somatic and 
psychomotor symptoms that are often confusing to older adults. However, it is important to 
remember that older adults are more likely to present with melancholic depression, some features 
of which are somatic (i.e., significant changes in weight) and psychomotor (i.e., psychomotor 
retardation or agitation) in nature (DSM-IV-TR, 2000). In fact, melancholic depression has been 
shown to lead to more psychomotor disturbance in older adults than in younger adults (Parker et 
al., 2001). By neglecting to assess this subset of systems, there might be an increased rate of 
false negatives when diagnosing depression in older adults. Thus, clinicians and researchers 
would benefit from the administration of both the GDS and the CES-D, in conjunction with a 
physical examination to ascertain the cause of any somatic symptoms (Blazer, 2003).                                                         
1 The long and short versions of the GDS are in the public domain. They may be found at 
www.stanford.edu/~yesavage/GDS.html 
  
Furthermore, tests of cognitive functioning such as the Mini-Mental State Examination (MMSE) 
or the Clinical Dementia Rating Scale should be given in order to assess whether (a) the 
individual is competent to self-report his or her symptoms and (b) the underlying cause of any 
cognitive impairments is dementia or another source of cognitive decline (Blazer, 2003; 
Montorio & Izal, 1996). The standardization of this diagnostic workup would lead to improved 
interclinician reliability and increased consistency across research studies. 
A major issue in the existing research on aging and depression is that cross-sectional studies 
can result in cohort effects; in other words, changes over time in education and awareness about 
mental health issues, availability of mental health resources, economic issues, average stress 
levels, and other factors may contribute to observed differences in depression between younger 
and older people (Wu et al., 2012; Yang, 2007). In this way, cross-sectional studies only tell us 
about the prevalence of depression in the current population, but they do not provide an accurate 
picture of how depression changes in individuals as a result of the aging process. In addition, 
there may be age bias in cross-sectional studies related to differential validity of the test items 
across age groups (Jorm, 2000). For these reasons, there is a need for more longitudinal research 
that assesses changes in depression in individuals over time. 
Another problem in the literature on late-life depression is that severely depressed elders are 
more likely to drop out of or miss observations in longitudinal studies (e.g. Beekman et al., 
2002). For this reason, our knowledge about severe depression is limited.  Future research 
attempts should focus on decreasing attrition in the most severely depressed old adults by 
offering additional compensation for full cooperation and complete participation in studies.  The 
self-report measures that are commonly used in studies of depression may be completed from the 
privacy of one’s home, which could make participation in these studies more attractive to 
severely depressed individuals.  Increased mortality in the clinically depressed elderly also leads 
to increased rates of attrition in both longitudinal and cross-sectional research (Blazer, 2003).  
Continued efforts to improve recognition and treatment of MDD and its precursors in the 
geriatric population will hopefully lead to improved prognoses for depressed individuals, which 
will, in turn, benefit future research efforts. 
Late-life depression is often comorbid with medical conditions as well as other psychiatric 
disorders. In fact, many general medical conditions have been shown to cause, exacerbate, or 
mimic depressive symptoms (Cooke & Tucker, 2001; DSM-IV-TR, 2000). For this reason, there 
have been attempts in relatively recent research to control for these comorbid conditions in order 
to tease apart the effects of aging on depression independent of other conditions.   
Blazer et al. (1991) discovered that frequency of depressive symptoms was associated with 
advanced age, being female, cognitive impairment, disability, and lack of social support. Without 
the inclusion of these factors in the regression analysis, there was a positive correlation between 
advanced age and depression in people over the age of 65. However, when these factors were 
controlled for, the association reversed, such that the oldest old participants had the fewest 
depressive symptoms. Similarly, Wu et al. (2012) identified that the linear increase in depressive 
symptoms in elderly people results from an increase in medical comorbidity in late life. After 
  
controlling for medical illness, there was no relationship between age and depressive symptoms. 
These findings convey that psychological and physiological factors associated with advanced age 
influence the frequency of depressive symptoms above and beyond the role of aging itself.  From 
these findings, we can also ascertain that some risk factors for late-life depression, such as 
availability of social support and seeking treatment for medical conditions, are potential sources 
of intervention in order to diminish the likelihood that some older people will develop 
depression.   
It is important to note that studies that utilize depressed elders do not always report or control 
for the age of onset of depression, thereby lumping together people who have had chronic 
depression since childhood and people who may have had their first Major Depressive Episode 
in their old age. There is evidence that late-onset depression is more likely to occur due to 
exogenous stressors, whereas early-onset depression is likely related to endogenous factors such 
as neuroendocrine dysregulation and genetics (Klein, 2010). These differences in etiology 
indicate that future studies should make an effort to control for onset.   
Future studies of aging and depression should continue to use scales such as the GDS that are 
designed to be short, simple, and easily visible to healthy older adults, who may be visually 
impaired or experiencing mild cognitive decline.  More research is also needed to fully 
understand the interaction of dementia and depression. Despite the relative simplicity of the 
GDS, it is not recommended for use with individuals who are more than mildly demented on the 
Clinical Dementia Rating scale (Montorio & Izal, 1996). Specifically, patients with dementia 
may not be able to accurately remember and report on their experience of depressive symptoms 
over the past week, as required by the GDS. Future research should attempt to develop new 
scales that clinicians can administer to more severely cognitively impaired individuals, perhaps 
by including reports from caregivers and asking patients to report their present symptoms rather 
than remembering past experiences of symptoms. This research will further scientific knowledge 
about the prevalence of depression in dementia patients in hopes of ultimately providing these 
individuals with accurate diagnoses and beneficial treatment plans, thereby improving their 
quality of life. 
 
Conclusions 
 
As the years pass, there will be increasing numbers of elderly adults in the population. They 
will be our co-workers, our neighbors, our family members, and someday, ourselves. Recent 
research has indicated that social workers, nurses, and other healthcare providers are not 
adequately trained to recognize and treat signs of depression in geriatric populations (Blazer, 
2003). It is exceedingly important to educate healthcare providers and the general public about 
the ways in which late-life depression differs from early-life depression in appearance, etiology, 
and appropriate treatment in order to improve recognition of depressive symptoms and increase 
the proportion of depressed elders who receive adequate treatment.  Furthermore, improved 
diagnostic success will lead to increased knowledge about the community prevalence of 
  
depression and changes in depression in individuals over time. 
For most people, old age is a time to focus on maintaining intimate relationships and reflect 
on the most meaningful achievements of their lives (Carstensen & Mikels, 2005). Since medical 
advances mean that we have greater longevity (Aw et al., 2007), we can be productive and happy 
members of our community for longer and accomplish more with the time we have. However, 
for some, aging and its associated stressors can result in mood disturbances such as major and 
minor depression, which significantly detract from their quality of life. Late-life depression is 
treatable, but improvements in research and clinical practice are needed to ensure that more 
people are accurately diagnosed and treated.  
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